CCR5 and neoplasm: These chemokines, through binding to CCR5 and CXCR3 receptors on T and NK cells, promote their migration from tumor-draining lymph nodes to the TME where they can recognize tumor antigens and become activated to eliminate tumor cells 28, 29.